Meiou Dai

915 total citations
21 papers, 703 citations indexed

About

Meiou Dai is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Meiou Dai has authored 21 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Meiou Dai's work include TGF-β signaling in diseases (7 papers), Cancer Cells and Metastasis (7 papers) and Cancer-related Molecular Pathways (6 papers). Meiou Dai is often cited by papers focused on TGF-β signaling in diseases (7 papers), Cancer Cells and Metastasis (7 papers) and Cancer-related Molecular Pathways (6 papers). Meiou Dai collaborates with scholars based in Canada, China and Saudi Arabia. Meiou Dai's co-authors include Suhad Ali, Jean‐Jacques Lebrun, Jun Tian, Jimin Guo, Ibrahim Y. Hachim, Ani Arakelian, Shafaat A. Rabbani, Sergio A. Burgos, Gang Yan and Mahmood Yaseen Hachim and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Cancer Research.

In The Last Decade

Meiou Dai

20 papers receiving 698 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meiou Dai Canada 15 470 300 161 92 76 21 703
Peter Sicinski United States 9 457 1.0× 262 0.9× 112 0.7× 89 1.0× 113 1.5× 9 680
Kyoung Eun Baek South Korea 13 432 0.9× 218 0.7× 109 0.7× 69 0.8× 75 1.0× 18 633
Virginie Maire France 9 401 0.9× 247 0.8× 165 1.0× 138 1.5× 38 0.5× 17 697
Huijie Yang China 15 501 1.1× 207 0.7× 155 1.0× 94 1.0× 111 1.5× 40 711
Özge Saatci United States 18 461 1.0× 230 0.8× 295 1.8× 107 1.2× 67 0.9× 29 749
Haizeng Zhang China 12 316 0.7× 266 0.9× 152 0.9× 128 1.4× 79 1.0× 42 752
Chuanwen Fan China 16 299 0.6× 287 1.0× 150 0.9× 98 1.1× 31 0.4× 45 682
Cynthia López‐Haber United States 15 605 1.3× 207 0.7× 100 0.6× 65 0.7× 171 2.3× 19 824
Minna Luo China 12 465 1.0× 314 1.0× 233 1.4× 67 0.7× 39 0.5× 28 723
Mary Jo Pilat United States 12 407 0.9× 230 0.8× 143 0.9× 68 0.7× 50 0.7× 25 669

Countries citing papers authored by Meiou Dai

Since Specialization
Citations

This map shows the geographic impact of Meiou Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiou Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiou Dai more than expected).

Fields of papers citing papers by Meiou Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meiou Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiou Dai. The network helps show where Meiou Dai may publish in the future.

Co-authorship network of co-authors of Meiou Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Meiou Dai. A scholar is included among the top collaborators of Meiou Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meiou Dai. Meiou Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Truesdell, Peter, Jessica Chang, Meiou Dai, et al.. (2024). Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes. npj Precision Oncology. 8(1). 186–186. 2 indexed citations
3.
Dai, Meiou, Ni Wang, Gang Yan, et al.. (2024). Genome-wide in vivo CRISPR screen identifies TGFβ3 as actionable biomarker of palbociclib resistance in triple negative breast cancer. Molecular Cancer. 23(1). 118–118. 11 indexed citations
4.
5.
Dai, Meiou, Gang Yan, Ni Wang, et al.. (2021). In vivo genome-wide CRISPR screen reveals breast cancer vulnerabilities and synergistic mTOR/Hippo targeted combination therapy. Nature Communications. 12(1). 3055–3055. 81 indexed citations
6.
Yan, Gang, Meiou Dai, Chenjing Zhang, et al.. (2021). TGFβ/cyclin D1/Smad-mediated inhibition of BMP4 promotes breast cancer stem cell self-renewal activity. Oncogenesis. 10(3). 21–21. 18 indexed citations
7.
Binothman, Najat, Ni Wang, Dana Hamam, et al.. (2021). Prolactin receptor-driven combined luminal and epithelial differentiation in breast cancer restricts plasticity, stemness, tumorigenesis and metastasis. Oncogenesis. 10(1). 10–10. 17 indexed citations
8.
Dai, Meiou, Ni Wang, Gang Yan, et al.. (2020). Differential Regulation of Cancer Progression by CDK4/6 Plays a Central Role in DNA Replication and Repair Pathways. Cancer Research. 81(5). 1332–1346. 32 indexed citations
9.
Tian, Jun, Meiou Dai, Baharak Khadang, et al.. (2018). Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells. British Journal of Cancer. 119(12). 1495–1507. 73 indexed citations
10.
Hachim, Mahmood Yaseen, Ibrahim Y. Hachim, Meiou Dai, Suhad Ali, & Jean‐Jacques Lebrun. (2018). Differential expression of TGFβ isoforms in breast cancer highlights different roles during breast cancer progression. Tumor Biology. 40(1). 3726136425–3726136425. 27 indexed citations
11.
Tian, Jun, et al.. (2018). Abstract 144: Dasatinib enhances the effects of paclitaxel on chemotherapy-resistant breast cancer through targeting breast cancer stem cells. Cancer Research. 78(13_Supplement). 144–144. 1 indexed citations
12.
Tian, Jun, et al.. (2017). Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer. Scientific Reports. 7(1). 40258–40258. 54 indexed citations
13.
Tian, Jun, Yun Wang, Meiou Dai, et al.. (2017). KiSS1 gene as a novel mediator of TGFβ-mediated cell invasion in triple negative breast cancer. Cellular Signalling. 42. 1–10. 24 indexed citations
14.
Dai, Meiou, Chenjing Zhang, Jun Tian, et al.. (2016). CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer. Scientific Reports. 6(1). 35383–35383. 51 indexed citations
15.
Guo, Jimin, Lucie Canaff, Charles Vincent Rajadurai, et al.. (2014). Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes. Breast Cancer Research. 16(6). 476–476. 23 indexed citations
16.
17.
Martin, Cyril, Zhong Ma, Anouar Hafiane, et al.. (2012). Engulfment Protein GULP Is Regulator of Transforming Growth Factor-β Response in Ovarian Cells. Journal of Biological Chemistry. 287(24). 20636–20651. 17 indexed citations
18.
19.
Cocolakis, Eftihia, Meiou Dai, Joanne Ho, et al.. (2007). Smad Signaling Antagonizes STAT5-mediated Gene Transcription and Mammary Epithelial Cell Differentiation. Journal of Biological Chemistry. 283(3). 1293–1307. 50 indexed citations
20.
Dai, Meiou, et al.. (1996). Time resolved annealing studies of single neutron irradiated avalanche photodiodes. IEEE Transactions on Nuclear Science. 43(6). 2595–2600. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Sicinski Breakdown of academic impact, for papers by Kyoung Eun Baek Breakdown of academic impact, for papers by Virginie Maire Breakdown of academic impact, for papers by Huijie Yang Breakdown of academic impact, for papers by Özge Saatci Breakdown of academic impact, for papers by Haizeng Zhang Breakdown of academic impact, for papers by Chuanwen Fan Breakdown of academic impact, for papers by Cynthia López‐Haber Breakdown of academic impact, for papers by Minna Luo Breakdown of academic impact, for papers by Mary Jo Pilat
Rankless by CCL
2026